IPD’s EU and EU+ subscriptions offer patent, regulatory, and competitive analysis, enabling you to stay ahead of changes in the marketplace and enhance strategic decision-making, with:

​

• Easy-to-use European brand,

      biosimilar, and generic drug

      launch tracking schedules
 

• European litigation tracking and

      in-the-courtroom coverage with

      real-time email updates
 

• ƒPersonalized consults with local European intellectual property analysts 
   

• ƒWeekly updates including European trending drug topics, recent publications,

       and loss-of-exclusivity information
 

• Complete European drug information with locally reviewed indications
   

• Comprehensive European clinical development tracking in every major disease class

​

In addition to our coverage of the EU5, IPD provides solutions to efficiently monitor loss of exclusivity, patents threatening innovator products, shifts in the competitive landscape, and litigation events affecting the broader market, including: 

​

• EPO Opposition Tracker 

• SPC Tracker

• National Litigation Tracker

• Expanded courtroom analysis covering Austria, Belgium, Bulgaria, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom, and proceedings at the Court of Justice of the European Union (including the General Court)